Skip to content

Dossier · WIX · Dormant

WIX · Wix.com Ltd. · Stock research

Last analysed ·

Current thesis

Base44 margin inversion is the live leg: Q2 2026 (2026-08-04) printed revenue $563.1M +15% and guided Base44 to ~60% non-GAAP gross margin in 2H from near-zero, into a float cut 29.7% at $92.00 in April and a ~26%-short base. Counterweight: bookings +12% lagged revenue on Partners softness and Q3 revenue is guided to low-double-digits, with no scheduled proof point until the ~November print.

Invalidation trigger

A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.

Thesis status

Open commitment scored if the trigger above fires How this is scored →

Latest analysis and events for WIX —

As of 2026-08-08, orbyd's latest analysis for Wix.com Ltd. (WIX): Base44 margin inversion is the live leg: Q2 2026 (2026-08-04) printed revenue $563.1M +15% and guided Base44 to ~60% non-GAAP gross margin in 2H from near-zero, into a float cut 29.7% at $92.00 in April and a ~26%-short base. Counterweight: bookings +12% lagged revenue on Partners softness and Q3 revenue is guided to low-double-digits, with no scheduled proof point until the ~November print.

Invalidation trigger: A weekly close below $52 fills the 2026-08-04 earnings gap and returns price to the pre-print base; secondary, Q3 bookings growth printing under Q2's +12% or an FY26 cut from low-teens bookings growth.

Prices referenced are split/dividend-adjusted daily closes; the working basis is the 2026-08-07 close of $60.20, -67.3% from the $184.24 52-week high, -24.9% over three months, RSI(14) 58.2.

WIX — Wix.com Ltd.

Current Thesis

The leg on offer is a margin inversion inside a wrecked chart. For eighteen months the market priced Wix as roadkill for general-purpose AI — anything that can write a site kills the company that sells site-building. Q2 2026, reported 2026-08-04, argued the opposite on the one line that matters: Base44, the AI app-creation platform, is guided to ~60% non-GAAP gross margin in 2H 2026 from near-zero entering the year, after launching its own model (Base 1). That lands into a float that the company itself cut by 29.7% at $92.00 in April and a short base reported near 26% of the remaining float. What is being bought is the claim that the AI product line stops being a cost centre and starts carrying the multiple.

The counterweight is in the same release: bookings +12% YoY ($569.1M) grew slower than revenue +15% ($563.1M), management attributed the gap to Partners softness, and Q3 2026 revenue is guided to low-double-digit YoY growth — a company-guided deceleration off the 15% just printed. Nothing company-scheduled resolves that until the Q3 print in roughly three months.

Bullish and bearish views on Wix.com Ltd.

The model's bull view on Wix.com Ltd. (WIX), in brief: Q2 2026 beat on both lines (2026-08-04): revenue $563.058M vs $554.444M consensus; adjusted EPS $1.39 vs $1.16 estimate (Benzinga, 2026-08-04). The bear view: Bookings lead revenue, and bookings are the weaker number. Both cases follow in full.

Bull Case

  • Q2 2026 beat on both lines (2026-08-04): revenue $563.058M vs $554.444M consensus; adjusted EPS $1.39 vs $1.16 estimate (Benzinga, 2026-08-04).
  • ARR $1.963B, +15% YoY at quarter-end; Creative Subscriptions $398.4M (+15%), Business Solutions $164.7M (+14%) — growth is not concentrated in one segment.
  • Base44 is the pivot, and it now has a number attached: ARR reached $150M by early May 2026, and the company guided the unit to ~60% non-GAAP gross margin in 2H versus near-zero at the start of 2026 (Q2 release/call, 2026-08-04). The proprietary Base 1 LLM is the stated mechanism — inference cost moves in-house.
  • Shares outstanding were 41,849,511 as of 2026-05-11. The board authorization approved 2026-01-27 runs to $2.0B through 2027-12-31 and covers shares and/or the 0.00% convertible senior notes due 2030.
  • Cash generation held through the restructuring: FCF $52.6M, $61.2M ex-restructuring (11% of revenue), with FY26 high-teens FCF margin ex-acquisition/restructuring reaffirmed.
  • Sell-side re-marked upward the day after the print (2026-08-05): RBC to $60 (Sector Perform), Wells Fargo to $64 (Equal-Weight), UBS to $66 (Neutral), Cantor to $80 (Overweight), Needham $80 (Buy, maintained), Benchmark to $90 (Buy) — Benchmark having cut to $85 on 2026-07-29. Evercore trimmed to $95 while keeping Outperform.

Bear Case

  • Bookings lead revenue, and bookings are the weaker number. +12% vs +15% in Q2 2026, with Partners softness named by management on 2026-08-04. That ordering shows up in reported revenue with a lag.
  • The company guided the deceleration itself: Q3 2026 revenue growth low-double-digits, below the 15% Q2 print.
  • $1.617B of shareholder capital cleared at $92.00 on 2026-04-03 against a $60.20 close on 2026-08-07. Roughly four-fifths of the $2.0B authorization was consumed above the current market, leaving a thinner corporate bid for the rest of the window to 2027-12-31.
  • GAAP is still red: Q2 2026 GAAP net loss $(76.4)M, or $(1.78) per share, against non-GAAP net income of $68.2M. GAAP gross margin 66%.
  • The damage is multi-quarter, not one gap. -24.9% over three months to 2026-08-07 and -67.3% from $184.24 means every rally works into supply laid down across a full year of higher prices, including the $92.00 tender clearing price where a large holder cohort exited.
  • Three of seven fresh targets sit at or barely above spot: RBC $60, Wells Fargo $64, UBS $66 (all 2026-08-05). The bull targets ($80–$95) require the Base44 margin ramp to land.

Setup & Price Structure

  • Basis: $60.20 close, 2026-08-07. RSI(14) 58.2 — mid-range, neither stretched nor washed out.
  • Two dated moves built this level: +21.3% across July 2026 (Motley Fool, 2026-08-07) and a roughly +18% reaction on the 2026-08-04 print (TIKR, 2026-08-04). The entire current structure rests on that gap; below it is the July base and, under that, the June low area.
  • Narrative life-cycle: ACCELERATING — but on a five-week-old leg, and only that leg. The story that carried the stock to $184.24 is finished; nothing about a -67.3% drawdown is being repaired by a single quarter. What is genuinely new dates to 2026-08-04: fresh headlines, seven target revisions in a single session (2026-08-05), and expanding attention on Base44 as a margin story rather than a defensive one. The honest framing is an early repair attempt with the burden of proof still on the company, not a resumed uptrend.
  • Crowding and positioning observables (stated, not judged): short interest reported near 26% of float into the print (BigGo Finance, 2026-08-04), corroborated in tone by Benzinga's 2026-08-04 headline framing Wix as a highly-short stock; the float itself is 29.7% smaller than in March, which mechanically raises short-as-percent-of-float for an unchanged share count short; seven analyst revisions clustered on one day into a $60–$95 band; no earnings date inside the next 30 days; and the company's own repurchase capacity is now the residual $2.0B authorization less the ~$1.617B tender.
  • Insider flow is unobservable here — as an Israeli foreign private issuer, Wix's insiders are exempt from Section 16, so no Form 4 stream exists to read. Absence of insider selling in this name carries no information.

Catalyst Calendar (next 30 days)

  • 2026-08-14 — settlement date for the next semi-monthly short-interest report; exchange publication ~2026-08-26 (est.). This is the first hard measurement of whether the ~26%-of-float short base covered into the 2026-08-04 gap or was rebuilt.
  • ~2026-09-03 (est.) — September technology-conference season. Wix has done Citi Global TMT fireside chats in prior years (announced 2025-08-21 for the 2025 event); no 2026 participation has been announced as of 2026-08-08, so treat this as a pattern, not a scheduled date.
  • ~2026-11-17 (est.) — Q3 2026 results. Q3 2025 was reported on 2025-11-19, which anchors the estimate. This is the first test of the low-double-digit Q3 revenue guide, whether Partners softness widened, and whether Base44 actually printed ~60% non-GAAP gross margin.
  • No confirmed company-scheduled event falls inside the window ending 2026-09-07. The name trades on flow, sector beta and short-interest mechanics until then.

What Would Change Our Mind

The whole structure is the 2026-08-04 gap. If that gap is filled, the beat has been fully absorbed and the operative structure reverts to the multi-quarter downtrend that produced -67.3% from $184.24. In level terms: a weekly close below $52 — roughly the launch area implied by the ~+18% print reaction — would say the market re-rejected the Base44 margin argument.

Fundamentally, three observables would break the leg:

  • Q3 bookings growth printing below Q2's +12%, or an FY26 bookings guide cut from low-teens — that would confirm Partners softness is spreading rather than isolated.
  • Base44 missing the ~60% non-GAAP gross-margin mark in 2H, or the metric quietly disappearing from disclosure. The company put that number on the record on 2026-08-04; it either lands in November or it does not.
  • FY26 revenue guidance cut from low-to-mid-teens. The reaffirmation on 2026-08-04 is doing a lot of work in every bull target from $80 to $95.

Conversely, the read strengthens if bookings growth re-crosses above revenue growth at the Q3 print, or if the company discloses material repurchase under the remaining authorization at prices near the current handle — capital deployed at $60 reads differently than capital deployed at $92.

Correlation Notes

  • SMB web-presence complex. WIX moves with GDDY and, more loosely, SHOP; Squarespace has been private since Permira's 2024 take-private, removing the closest pure comparable from the tape. Inference, not measurement: the derating from $184.24 to $60.20 tracks the market's repricing of DIY site-building as general-purpose models absorb the task. A peer print showing the same channel/Partners softness would generalize the Q2 bookings gap from company-specific to sector-wide.
  • High-short-interest cohort. With a reported ~26% of a 29.7%-reduced float short, WIX will co-move with squeeze-sensitive names on broad risk-on days independent of company news. That correlation cuts both directions and decays as the short base is measured down.
  • Capital structure. The 0.00% convertible senior notes due 2030 sit inside the same $2.0B authorization as the equity, so rate moves and the converts' price change the relative attractiveness of buying stock versus buying paper — the same dollars have two homes.
  • Israel-domiciled issuer. Regional escalation has historically repriced Israeli tech listings as a bloc regardless of company fundamentals; the observable is the Israeli ADR complex gapping together on headline days.

Notes

  • Israeli foreign private issuer: reports on 20-F/6-K, not 10-Q/10-K, and insiders are Section 16 exempt — Form 4 insider screens are structurally blind on this name.
  • Share count fell ~29.7% via the tender completed 2026-04-03; per-share comparisons spanning that date are not like-for-like.
  • Capital structure includes 0.00% convertible senior notes due 2030, which the $2.0B board authorization may repurchase alongside common shares.
  • GAAP and non-GAAP diverge materially: Q2 2026 showed a $(76.4)M GAAP net loss against $68.2M non-GAAP net income.

Related · shared themes

HPE

Hewlett Packard Enterprise Company

Five straight up sessions took HPE to a $53.22 close on 2026-08-07 with the 2026-08-04 gap floor at $50.24 still untested; Trefis put the five-day move at +19.8% against +5.6% for the S&P 500, so this leg is no longer pure sector beta. Forward P/E 13.79 versus 49.66 trailing. The still-unconfirmed ~2026-09-02 Q3 print against the $11.5–12.1B / $0.88–0.93 guide is the binary.

MEDIUM

OKTA

Okta, Inc.

Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme ACCELERATING, this leg maturing; open risk is paying up for a stretched 52-week-high tape.

MEDIUM

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW

SNX

TD SYNNEX Corporation

The 2026-08-04 breakout above the July band failed within three sessions — SNX closed $252.42 on 2026-08-07, back inside the $235.67–$255.70 range and under the 50-day. The move up came on Arista's print, not company news; Hyve's +117% billings leg stays unconfirmed until ~2026-09-24, and the nearest dated read is Dell on 2026-09-03.

LOW

See also · stocks to watch